Table 1.
Design of the in vitro experiment
| Group no.a | Administrationb | Treatment days 1–3° | Treatment days 3–5c | |||
|---|---|---|---|---|---|---|
| Drug | Concentrationd | Drug | Concentrationd | |||
| 1 | A | Sequential | MTA | 0.04 | GEM | 0.04 |
| B | 0.16 | |||||
| C | 0.64 | |||||
| D | 2.56 | |||||
| E | 10.24 | |||||
| 2 | A | Sequential | GEM | 0.02 | MTA | 0.02 |
| B | 0.08 | |||||
| C | 0.34 | |||||
| D | 1.36 | |||||
| E | 5.43 | |||||
| 3 | A | Simultaneous | – | – | MTA/GEM | 0.02/0.04 |
| B | 0.02/0.16 | |||||
| C | 0.02/0.64 | |||||
| D | 0.02/2.56 | |||||
| E | 0.02/10.24 | |||||
| 4 | A | Simultaneous | – | – | GEM/MTA | 0.04/0.02 |
| B | 0.04/0.08 | |||||
| C | 0.04/0.34 | |||||
| D | 0.04/1.36 | |||||
| E | 0.04/5.43 | |||||
a)Groups a–e were treated alike initially (days 1–3) and thereafter by different drug concentrations (days 3–5)
b)3×103 CC531 lacZ cells were grown for 24 h in 96-well plates and then exposed to treatment
c)the first treatment period was terminated by changing the medium and adding fresh medium containing the second treatment
d)µM